Discern Health

News

W2O has bought US health economics and outcomes research company Discern Health, marking its sixth acquisition in less than a year.

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.